Literature DB >> 15565300

Signs of rapidly progressive dementia in a case of intravascular lymphomatosis.

R Albrecht1, B Krebs, E Reusche, M Nagel, R Lencer, H A Kretzschmar.   

Abstract

Intravascular lymphomatosis (IVL), a rare type of non-Hodgkin's lymphoma, is an uncommon cause of progressive dementia, usually followed by death within a few months of onset of clinical disease. Often this aggressive tumor is only diagnosed at autopsy, because of misleading clinical features mimicking a broad spectrum of syndromes and the absence of circulating lympoma cells in the blood, bone marrow or cerebrospinal fluid in many cases. Here we present IVL in a 78-year-old woman with findings leading to the clinical diagnosis of vascular dementia with sudden beginning and positive 14-3-3 protein in the CSF, commonly reported in Creutzfeldt-Jakob disease (CJD).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15565300     DOI: 10.1007/s00406-004-0551-9

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  29 in total

1.  Angiotropic lymphoma (malignant angioendotheliomatosis) presenting with rapidly progressive dementia.

Authors:  M Drlicek; W Grisold; U Liszka; P Hitzenberger; E Machacek
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  "Intravascular lymphomatosis" (angioendotheliomatosis): evidence for a T-cell origin in two cases.

Authors:  N Sepp; G Schuler; N Romani; D Geissler; C Gattringer; G Burg; C R Bartram; P Fritsch
Journal:  Hum Pathol       Date:  1990-10       Impact factor: 3.466

Review 3.  Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature.

Authors:  T Murase; S Nakamura; K Tashiro; T Suchi; J Hiraga; N Hayasaki; M Kimura; M Murakami; Y Mizoguchi; T Suzuki; H Saito
Journal:  Br J Haematol       Date:  1997-12       Impact factor: 6.998

4.  The neurological masquerade of intravascular lymphomatosis.

Authors:  Xabier Beristain; Biagio Azzarelli
Journal:  Arch Neurol       Date:  2002-03

5.  Intravascular lymphomatosis. A systemic disease with neurologic manifestations.

Authors:  J Glass; F H Hochberg; D C Miller
Journal:  Cancer       Date:  1993-05-15       Impact factor: 6.860

6.  Immunohistochemical and cytogenetic studies indicate that malignant angioendotheliomatosis is a primary intravascular (angiotropic) lymphoma.

Authors:  A Molina; C Lombard; T Donlon; C D Bangs; R F Dorfman
Journal:  Cancer       Date:  1990-08-01       Impact factor: 6.860

7.  Malignant angioendotheliomatosis. An angiotropic lymphoma?

Authors:  U Wrotnowski; S E Mills; P H Cooper
Journal:  Am J Clin Pathol       Date:  1985-02       Impact factor: 2.493

8.  Malignant angioendotheliomatosis (intravascular lymphomatosis) clinically simulating primary angiitis of the central nervous system.

Authors:  J T Lie
Journal:  Arthritis Rheum       Date:  1992-07

9.  Further evidence that "malignant angioendotheliomatosis" is an angiotropic large-cell lymphoma.

Authors:  K Sheibani; H Battifora; C D Winberg; J S Burke; J Ben-Ezra; G M Ellinger; N J Quigley; B B Fernandez; D Morrow; H Rappaport
Journal:  N Engl J Med       Date:  1986-04-10       Impact factor: 91.245

Review 10.  Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy.

Authors:  J A DiGiuseppe; W G Nelson; E J Seifter; J K Boitnott; R B Mann
Journal:  J Clin Oncol       Date:  1994-12       Impact factor: 44.544

View more
  2 in total

Review 1.  Differential diagnosis of white matter lesions: Nonvascular causes-Part II.

Authors:  S Weidauer; M Nichtweiss; E Hattingen
Journal:  Clin Neuroradiol       Date:  2014-02-12       Impact factor: 3.649

2.  Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy.

Authors:  Sied Kebir; Klaus Kuchelmeister; Pitt Niehusmann; Michael Nelles; Young Kim; Sharmilan Thanendrarajan; Niklas Schäfer; Moritz Stuplich; Frederic Mack; Björn Scheffler; Horst Urbach; Martin Glas; Ulrich Herrlinger
Journal:  Exp Hematol Oncol       Date:  2012-12-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.